Experts fear the chilling effect of rewriting Covid vaccine guidance

Also: How cautious culture cost Novo Nordisk its lead in the obesity drug race, according to former employees

June 5, 2025 Check out STAT+

Sponsored By

Molly Ferguson for STAT STAT+ | A cautious culture cost Novo Nordisk its lead in the obesity drug race, former employees say Novo Nordisk's stock is down, the CEO is out, and Eli Lilly is ascendant. Danish drugmaker projects confidence, but R&D veterans say caution carried a cost. By Elaine Chen STAT+ | Lawmakers lobby doctors to keep quiet — or speak up — on Medicaid cuts in Trump's tax bill GOP tells lobbyists for doctors the 'big, beautiful bill' gives MDs a pay raise. Democrats want physicians to speak out on damage from Medicaid cuts. By Daniel Payne STAT+ | Taurine, a darling of longevity seekers, is found to be unreliable biomarker for aging The Red Bull ingredient and popular longevity supplement surged in popularity after a 2023 study on aging in mice. A new study casts doubt on those findings. By Jason Mast Eraldo Peres/AP Rewriting of Covid vaccine recommendations has doctors and other experts worried New policy expected to result in Covid shots being harder to access, with fewer doctors choosing to stock them, fewer pharmacies willing to administer them. By Helen Branswell GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds A study of people with diabetes found the risk of macular degeneration remained low, but was 0.2% in people taking GLP-1s, 0.1% in those who didn't. By Elizabeth Cooney STAT+ | MoonLake Immunotherapeutics is for sale? This sounds like a cry for help In this week's edition of Adam's Biotech Scorecard, Adam also takes on the PD(L)1-VEGF antibody cancer treatments garnering so much attention. By Adam Feuerstein Adobe Massive NIH study challenges use of race as a proxy for genetic ancestry in research Study urges rethinking race in science but politics, misinterpretation may obscure key finding: Self-reported race a poor proxy for genetics By Anil Oza

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser